Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

American Journal of Hematology(2023)10.1002/ajh.26908Source: DataRank Database

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions is a research paper published in American Journal of Hematology (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.39)OA: hybridTopics (21)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Michelle Afkhami ORCID,Dongyun Yang ORCID,Zhaohui Gu ORCID,Sally Mokhtari,Shilpa Shahani

Live enrichment

PubMed:36880203 OpenAlex:https://openalex.org/W4323348553

National Cancer Institute

Grant: CA033572

NCI NIH HHS

Grant: P30 CA033572

FWCI

4.39

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26908

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26908

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26908

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ajh.26908

journalhttps://doi.org/10.1002/ajh.26908

Fields of Study

Acute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

MeSH Terms

Inotuzumab OzogamicinAdultHumansRemission InductionRetrospective StudiesAntibodies, BispecificHematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Keywords

Lymphoblastic LeukemiaRefractory (planetary science)MedicineAcute lymphocytic leukemiaYoung adultLeukemiaOncologyCancer researchInternal medicineBiology

Sustainable Development Goals

SDG 0: Good health and well-being